glp 1 agonist addiction GLP-1 Receptor Agonists in Treatment: The Next Big Thing or Just Hype? GLP-1 medications get at the
Description
10.1038/s42255-024-01041-8 132 YustaB.BaggioL
Operationally, GLP-1 therapies have also increased the administrative burden
Triggs EJ, Johnson JM, Learoyd B
Patients who develop symptoms of pancreatitis (e.g., upper abdominal pain radiating to the back, nausea, vomiting) should be evaluated promptly, and tirzepatide should be discontinued if pancreatitis is confirmed
But the landscape shifted dramatically in early 2025, and understanding the current regulatory environment is critical before exploring this option
